RAD7 Antibody

What is RAD7 and what is its role in DNA repair mechanisms?

RAD7 is a component of a cullin-based E3 ubiquitin ligase complex that plays a critical role in nucleotide excision repair (NER). It exhibits structural similarity to F-box subunits of SCF-type ubiquitin ligases and forms a complex with Rad16, Elc1, and Cul3 proteins. This complex functions as an E3 ubiquitin ligase that mediates the ubiquitination of Rad4 protein in response to UV radiation. RAD7 specifically regulates NER pathway II, which is dependent on de novo protein synthesis following UV radiation damage. This pathway represents part of a transcriptional response that operates following DNA damage .

What types of RAD7 antibodies have been validated for research applications?

Several RAD7 antibodies have been successfully utilized in scientific research. These include:

Polyclonal antibodies raised against RAD7 have been successfully employed in immunoprecipitation experiments to study protein-protein interactions within the E3 ubiquitin ligase complex . Additionally, antibodies against epitope-tagged versions of RAD7 (such as Flag-tagged RAD7) have demonstrated efficacy in Western blotting, immunoprecipitation, and immunofluorescence studies .

How can researchers validate the specificity of RAD7 antibodies?

Validating RAD7 antibody specificity is crucial for reliable experimental outcomes. A methodological approach includes:

• Compare Western blot results from wild-type extracts with those from RAD7 deletion mutants (Δrad7 cells). A specific antibody should detect a band of appropriate molecular weight in wild-type extracts but show no corresponding band in Δrad7 extracts .

• Analyze immunoprecipitation results from both wild-type and Δrad7 strains. Co-precipitating proteins (Rad16, Elc1, Cul3) should only be detected in wild-type samples when using a specific RAD7 antibody .

• Perform antibody inhibition experiments in functional assays. Addition of RAD7-specific antibodies to in vitro ubiquitination assays should inhibit activity if the antibody is specific, while non-specific antibodies should have no effect .

• Use multiple antibodies targeting different epitopes to confirm findings across different detection methods.

How should researchers optimize RAD7 antibody use in immunoprecipitation studies?

For effective immunoprecipitation using RAD7 antibodies, researchers should implement the following protocol:

• Prepare cell extracts under non-denaturing conditions to preserve protein-protein interactions.

• Use polyclonal RAD7 antibodies for immunoprecipitation of RAD7 and its interacting partners (Rad16, Elc1, and Cul3) .

• Include appropriate controls:

  • Negative control: Perform parallel immunoprecipitation from Δrad7 extracts

  • Specificity control: Use non-specific antibodies of the same isotype

  • Input control: Analyze a portion of the extract before immunoprecipitation

• For detection of co-precipitating proteins, use Western blotting with specific antibodies against expected interaction partners (Rad16, Elc1, Cul3) .

• When investigating UV-induced changes in complex formation, compare immunoprecipitates from UV-treated versus untreated samples.

This approach has successfully demonstrated that RAD7 forms a complex with Rad16, Elc1, and Cul3 proteins, functioning as an E3 ubiquitin ligase .

What are the optimal conditions for detecting ubiquitinated RAD4 using RAD7 antibodies?

Detection of RAD4 ubiquitination mediated by the RAD7 E3 ligase complex requires careful experimental design:

• Express tagged ubiquitin (e.g., Myc-tagged ubiquitin) in yeast strains expressing either wild-type RAD7 or SOCS box-mutated RAD7 (psocs) .

• Expose cells to UV radiation to stimulate the ubiquitination process.

• Immunoprecipitate RAD4 protein using specific antibodies.

• Perform Western blotting with anti-tag antibodies (e.g., anti-Myc) to detect ubiquitinated forms of RAD4 .

• Include appropriate controls:

  • Untagged ubiquitin strain as negative control

  • Non-irradiated samples to establish baseline ubiquitination

  • RAD7 SOCS box mutant (psocs) to demonstrate E3 ligase dependency

This methodology has revealed that RAD4 protein is ubiquitinated in response to UV in strains with wild-type RAD7, but not in strains with SOCS box-mutated RAD7, confirming the E3 ligase activity of the RAD7 complex .

How can RAD7 antibodies be effectively used in immunofluorescence studies?

For optimal immunofluorescence detection of RAD7, researchers should follow these methodological steps:

• Sample preparation:

  • Fix cells with 2% paraformaldehyde for 10 minutes

  • Permeabilize with 0.5% Triton X-100 for 10 minutes after blocking with 1% BSA

• Antibody incubation:

  • Primary incubation: Apply rabbit anti-RAD7 antibody at room temperature (25°C) for 1 hour

  • Secondary detection: Use fluorophore-conjugated secondary antibodies (e.g., Alexa Fluor647-conjugated goat anti-rabbit antibody)

• High-resolution imaging:

  • For detailed visualization, employ stimulated emission depletion (STED) microscopy

  • This approach allows super-resolution imaging of RAD7 and potential co-localization with interaction partners

• Controls:

  • Include samples without primary antibody

  • Use RAD7-deficient cells as negative controls

  • For co-localization studies, include single-stained samples to rule out bleed-through

This technique has been successfully applied to visualize the subcellular localization of RAD7 and its potential co-localization with other proteins such as CD40 .

How can researchers investigate the role of RAD7's SOCS box domain using specific antibodies?

Investigation of RAD7's SOCS box domain requires a systematic experimental approach:

• Generate appropriate strains:

  • Wild-type RAD7 (pRAD7)

  • SOCS box-mutated RAD7 (psocs)

• Ubiquitination assays:

  • Immunoprecipitate RAD4 from strains expressing Myc-tagged ubiquitin

  • Western blot with anti-Myc antibody to detect ubiquitinated RAD4

  • Compare results between wild-type and psocs strains

• Functional assessment:

  • Measure UV survival in wild-type versus psocs strains

  • Quantify UV lesion removal efficiency in both strains

  • Assess effects of cycloheximide treatment on NER in both strains

• Protein complex analysis:

  • Immunoprecipitate RAD7 from both strains

  • Western blot for co-precipitating proteins (Rad16, Elc1, Cul3)

  • Determine whether SOCS box mutations affect complex formation

This methodological approach has demonstrated that the RAD7 SOCS box is essential for the ubiquitination of RAD4 in response to UV radiation and for the regulation of NER pathway II .

For in vitro analysis of RAD7 E3 ligase activity, researchers should follow this methodological approach:

• Protein purification:

  • Purify epitope-tagged RAD7 protein through multiple chromatographic steps

  • Confirm co-purification of complex components (Rad16, Elc1, Cul3) by Western blotting

• Ubiquitination assay setup:

  • Express RAD4 protein using a coupled transcription/translation system

  • Combine purified RAD7 complex with RAD4 in an ubiquitination reaction containing:

    • Ubiquitin

    • ATP

    • E1 and E2 enzymes

• Activity confirmation:

  • Detect ubiquitinated RAD4 by Western blotting

  • Perform inhibition controls by adding antibodies specific to RAD7 or RAD16

• Mutant analysis:

  • Compare ubiquitination activity of wild-type versus mutant RAD7 complexes

  • Analyze the effects of specific domain mutations on substrate recognition and ubiquitination efficiency

This approach has successfully demonstrated that the RAD7-containing complex functions as an E3 ubiquitin ligase capable of ubiquitinating RAD4 protein in vitro .

What are common challenges when using RAD7 antibodies in protein complex studies?

When studying RAD7-containing protein complexes, researchers should be aware of these methodological challenges and solutions:

• Complex stability issues:

  • Challenge: RAD7 complexes may dissociate during experimental procedures

  • Solution: Use gentle lysis conditions and optimize buffer composition (salt concentration, detergent type/concentration)

• Variable co-precipitation efficiency:

  • Challenge: Not all complex components co-precipitate equally with RAD7

  • Solution: Some components (e.g., Elc1, Cul3) participate in multiple distinct complexes, necessitating careful interpretation of co-IP results

• UV-induced changes:

  • Challenge: Complex composition may change following UV treatment

  • Solution: Perform time-course experiments after UV treatment to capture dynamic interactions

• Antibody specificity:

  • Challenge: Ensuring antibody specifically recognizes RAD7 in complex context

  • Solution: Validate using extracts from Δrad7 cells as negative controls

• Detecting transient interactions:

  • Challenge: Some interactions may be short-lived or condition-specific

  • Solution: Consider crosslinking approaches to stabilize transient interactions

Addressing these challenges has enabled researchers to demonstrate that RAD7 forms a complex with Rad16, Elc1, and Cul3, functioning as an E3 ubiquitin ligase in the nucleotide excision repair pathway .

How can researchers distinguish between RAD7's role in DNA repair and other cellular processes?

Differentiating RAD7's functions requires systematic experimental approaches:

• Domain-specific mutations:

  • Generate mutations in specific RAD7 domains (e.g., SOCS box)

  • Compare phenotypes between domain-specific mutants and complete RAD7 deletion

• Pathway-specific assays:

  • Measure UV sensitivity to assess general NER function

  • Quantify UV lesion removal in the presence/absence of cycloheximide to distinguish between repair pathways

  • Analyze ubiquitination of specific targets following different cellular stresses

• Genetic interaction analysis:

  • Combine RAD7 mutations with mutations in genes involved in:

    • Different DNA repair pathways

    • Protein degradation (e.g., 19S proteasome components)

    • Transcriptional regulation

• Temporal studies:

  • Analyze RAD7 function at different time points after DNA damage

  • Determine when RAD7 E3 ligase activity is required during the repair process

This methodological approach revealed that the RAD7 E3 ligase specifically regulates NER pathway II (requiring de novo protein synthesis) and functions independently of the RAD23/19S proteasome regulatory complex pathway .

How should researchers analyze conflicting data regarding RAD7 function across different experimental systems?

When faced with apparently contradictory results about RAD7 function, researchers should implement the following analytical approach:

• System-specific factors analysis:

  • Compare experimental conditions (cell types, species differences)

  • Evaluate potential differences in RAD7 expression levels across systems

  • Consider post-translational modifications that might vary between systems

• Methodological differences evaluation:

  • Analyze antibody specificity across different studies

  • Compare detection methods (direct detection vs. epitope tags)

  • Evaluate extraction and experimental conditions

• Genetic background considerations:

  • Assess the presence of compensatory mechanisms in different genetic backgrounds

  • Consider potential redundant pathways that might mask phenotypes in certain systems

• Functional assay sensitivity:

  • Compare the sensitivity and specificity of different functional assays

  • For DNA repair studies, consider different damage types and detection methods

• Pathway interaction analysis:

  • Determine whether RAD7 functions differently depending on the status of interacting pathways

  • Analyze genetic interactions with components of related pathways

This analytical framework helps reconcile seemingly conflicting observations, such as normal UV survival but defective NER in RAD7 SOCS box mutants .

What quantitative methods should be used to analyze RAD7-dependent ubiquitination events?

For rigorous quantification of RAD7-dependent ubiquitination, researchers should implement these analytical methods:

• Western blot densitometry:

  • Quantify the intensity of ubiquitinated RAD4 bands in wild-type versus RAD7 mutant backgrounds

  • Calculate the ratio of ubiquitinated to non-ubiquitinated forms

  • Perform time-course analysis following UV exposure

• In vivo ubiquitination analysis:

  • Immunoprecipitate target proteins from cells expressing tagged ubiquitin

  • Quantify ubiquitination by Western blotting with anti-tag antibodies

  • Compare results between wild-type and RAD7-mutant conditions

• In vitro ubiquitination kinetics:

  • Measure the rate of ubiquitin incorporation in reconstituted reactions

  • Compare kinetic parameters (Km, Vmax) between wild-type and mutant RAD7 complexes

• Ubiquitin chain topology analysis:

  • Use chain-specific antibodies to distinguish between different ubiquitin linkages

  • Determine whether RAD7 preferentially catalyzes specific chain types (K48, K63, etc.)

These quantitative approaches have revealed that RAD4 protein is ubiquitinated in a RAD7 E3 ligase-dependent manner following UV radiation, and this ubiquitination is specifically dependent on the SOCS box domain of RAD7 .